Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
03/21/2007 | EP1439176B1 Pyrimidone compounds and pharmaceutical compositions containing the same |
03/21/2007 | EP1401826B1 Pyrazole derivatives as hiv reverse transcriptase inhibitors |
03/21/2007 | EP1345943B1 Inhibitors of papilloma virus |
03/21/2007 | EP1112270B1 Dihydrobenzodioxine carboxamide and ketone derivatives as 5-ht4 receptor antagonists |
03/21/2007 | CN1934115A Diastereoselective epoxidation of allylically substituted alkenes using metalloporphyrin catalysts |
03/21/2007 | CN1934103A Fused heterocycle derivative, medicinal composition containing the same, and medicinal use thereof |
03/21/2007 | CN1934101A Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
03/21/2007 | CN1934100A Substituted quinazoline or pyridopyrimidine derivative |
03/21/2007 | CN1934097A Acetylinic piperazine compounds and their use as metabotropic glutamate receptor antagonists |
03/21/2007 | CN1934094A Diaryl-substituted five-membered heterocycle derivative |
03/21/2007 | CN1934091A Imidazole compounds for the treatment of neurodegenerative disorders |
03/21/2007 | CN1934088A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
03/21/2007 | CN1934087A Novel phenantridine analogues and their uses as inhibitors of hyperproliferation of T cells and/or keratinocytes |
03/21/2007 | CN1934083A 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension |
03/21/2007 | CN1934081A Novel benayl(idene)-lactam derivatives |
03/21/2007 | CN1933839A Compounds and methods of use |
03/21/2007 | CN1933838A Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
03/21/2007 | CN1933830A Indole derivatives and use thereof as kinase inhibitors in particular ik. k.2 inhibitors |
03/21/2007 | CN1931827A 2- and 2,5-substituted phenylketo-enols |
03/21/2007 | CN1305872C Process for producing quinazoline ditosylate salt compounds |
03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
03/21/2007 | CN1305853C Process for the manufacture of HMG-coa reductase inhibitors |
03/21/2007 | CN1305852C Diaryl ethers as opioid receptor antagonist |
03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
03/21/2007 | CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
03/20/2007 | US7193080 Color photography |
03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
03/20/2007 | US7192979 EP4 receptor selective agonist in the treatment of osteoporosis |
03/20/2007 | US7192978 Pyrrolidinium derivatives |
03/20/2007 | US7192976 3-substituted pyrazoles; cell proliferation and angiogenesis promoters; antiapoptotosis and antifibrosis activity |
03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
03/20/2007 | US7192971 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
03/20/2007 | US7192960 Sodium channel blockers |
03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
03/20/2007 | US7192953 Antibacterial agents |
03/20/2007 | US7192950 Psychological disorders; eating disorders; dietetics |
03/20/2007 | US7192944 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof |
03/20/2007 | CA2211320C 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2 |
03/15/2007 | WO2007029847A1 Bicyclic aromatic substituted pyridone derivative |
03/15/2007 | WO2007029587A1 β SECRETASE INHIBITOR |
03/15/2007 | WO2007029216A1 Preparation of an atorvastatin intermediate |
03/15/2007 | WO2007029156A2 Isoindoledione derivatives as adrenergic receptor antagonists |
03/15/2007 | WO2006138528A3 Tricyclic opioid modulators |
03/15/2007 | WO2006128692A3 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
03/15/2007 | US20070060754 Alkoxy substituted imidazoquinolines |
03/15/2007 | US20070060629 Large conductance calcium-activated k channel opener |
03/15/2007 | US20070060624 Novel bioisosteres of actinonin |
03/15/2007 | US20070060619 Nicotinamide-based kinase inhibitors |
03/15/2007 | US20070060616 Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compounds |
03/15/2007 | US20070060583 2-tert-Butyl-N,N-diethyl-1-{[1-methylpiperidin-2-yl]methyl}-1H-benzimidazole-5-carboxamide; cannabinoid receptors agonists; analgesic, anticarcinogenic, antiinflammatory, anxiolytic agent; neurodegenerative diseases; gastrointestinal and cardiovascular disorders |
03/15/2007 | US20070060582 1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
03/15/2007 | US20070060570 Sulfopyrroles |
03/15/2007 | US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors |
03/15/2007 | US20070060566 Benzazepine derivatives as histamine h3 antagonists |
03/15/2007 | CA2621506A1 Preparation of an atorvastatin intermediate |
03/15/2007 | CA2621470A1 Bicyclic aromatic substituted pyridone derivative |
03/15/2007 | CA2620491A1 Pharmaceutical dosage forms and compositions comprising lecoztan |
03/14/2007 | EP1762567A1 Pyrazole derivatives for treating HIV |
03/14/2007 | EP1761531A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
03/14/2007 | EP1761524A1 Phenyl diazepane carboxamides and annelated phenyl piperazine carboxamides containing oxygen and used as dopamine d3 antagonists |
03/14/2007 | EP1761522A1 Compounds and methods for treating dyslipidemia |
03/14/2007 | EP1761519A1 Indole derivatives as histamine receptor antagonists |
03/14/2007 | EP1761506A1 Substituted quinazolones as anti-cancer agents |
03/14/2007 | EP1761505A1 Pyrimidine urea derivatives as kinase inhibitors |
03/14/2007 | EP1761500A1 Pesticidal n-phenylpyrazole derivatives |
03/14/2007 | EP1761497A2 Azadecalin glucocorticoid receptor modulators |
03/14/2007 | EP1761491A1 Novel piperidine/8-azabicyclo [3.2.1] octan derivatives as moduilators of chemokine receptor ccr5 |
03/14/2007 | EP1040103B1 Anilide derivative, production and use thereof |
03/14/2007 | CN1930173A Process for preparing cephalosporin intermediates using alpha-iodo-1-azetidineacetic acid esters and trialkylphosphites |
03/14/2007 | CN1930152A 1,3-dioxane derivatives and analogues thereof useful in the treatment of I.A. obesity and diabetes |
03/14/2007 | CN1930144A 3-'4-heterocyclyl -1,2,3,-triazol-1-yl!-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
03/14/2007 | CN1930135A Diaminopyrimidines as P2X3 and P2X2/3 antagonists |
03/14/2007 | CN1930126A 吡啶酮衍生物 Pyridine derivatives |
03/14/2007 | CN1929848A Benzodiazepines for treating or preventing or preventing RSV infection |
03/14/2007 | CN1929738A Substituted 4-(4-trifluoromethylpyrazolyl)-pyrimidines serving as herbicides |
03/14/2007 | CN1304390C Novel gamma secretase inhibitors |
03/14/2007 | CN1304388C Process for synthesizing chiral N-aryl piperazines |
03/14/2007 | CN1304377C Metalloproteinase inhibitors |
03/14/2007 | CN1304374C Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition |
03/14/2007 | CN1303998C Pharmaceutical formulations containing darifenacin |
03/13/2007 | US7189861 Ball milling any crystalline form of atorvastatin hemi-calcium to obtain a polymorphic crystal structure with small particle size distribution; monodispersity; improved physical properties of filtration/drying characteristics, flowability, vapor impermeability, solubility; drug-releasing design |
03/13/2007 | US7189758 2-Benzyl-2-hydroxy-4-methyl-4-phenylpentanoic acid (1-oxo-1,3-dihydroisobenzofuran-5-yl)amide for example; treating type II diabetes, obesity, hypertension, arteriosclerosis, or glaucoma |
03/13/2007 | US7189757 Sleep disorders; side effect reduction |
03/13/2007 | US7189756 Pyrrolidine derivatives |
03/13/2007 | US7189745 For use in therapy of diseases, in a mammal, in which inappropriate, excessive or undesirable angiogenesis has occurred and/or where excessive Tie2 receptor activity has occurred, cytokine antagonist, antiarthritic agent, for therapy of diabetic retinopathy |
03/13/2007 | US7189741 Indolylpiperidine derivatives as antihistaminic and antiallergic agents |
03/13/2007 | US7189734 Anilinoquinazaolines as protein tyrosine kianse inhibitors |
03/13/2007 | US7189728 Inhibitors of dipeptidyl peptidase IV |
03/13/2007 | US7189724 For therapy of viral diseases |
03/13/2007 | US7189719 Sodium channel blockers |
03/13/2007 | US7189718 viricides; polymerase inhibitor; therapy for genetic engineered viruses |
03/13/2007 | US7189714 Administering quinoline derivative as analgesic |
03/13/2007 | US7189519 Identifying bound modified g-protein coupled receptors assemblies; microarrays; drug screening; colorimetric analysis |
03/13/2007 | CA2351049C Process for recovery of the desired cis-1,3-oxathiolane nucleosides from their undesired trans-isomers |
03/13/2007 | CA2274592C Pyrazole derivatives |
03/13/2007 | CA2176181C D4t polymorphic form i process |
03/08/2007 | WO2007027959A1 Novel benzopyran derivatives as potassium channel openers |
03/08/2007 | WO2007027780A2 Benzopyran and pyranopyridine derivatives as potassium channel openers |
03/08/2007 | WO2007026664A1 Sulfonamide compound |